Why the study?
Does dalteparin 5000 IU once daily prevent venous thromboembolism in acutely ill medical patients?
Does dalteparin 5000 IU once daily prevent venous thromboembolism in acutely ill medical patients?
Dalteparin 5000 IU once daily reduces the rate of venous thromboembolism in acutely ill medical patients with a low risk of bleeding.
Answers are grounded in this paper and cite their sources.
Supports dalteparin 5000 IU daily VTE prophylaxis in acutely ill medical patients; confirms efficacy from this RCT.
Dalteparin 5000 IU once daily halved the rate of venous thromboembolism with a low risk of bleeding.
No takes yet. Share an insight, caveat, or question.
Leizorovicz et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: